✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Albert David Ltd.

ALBERTDAVD

Market Cap
₹409 Cr.
P/E
0.00

Albert David Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
409 Cr
PE
PE
-
Prom Holding
Prom Holding
62.24 %
ROE (%)
ROE (%)
4.38
ROCE (%)
ROCE (%)
6.33
Div Yield (%)
Div Yield (%)
0.70
Sales
Sales
333 Cr
OPM (%)
OPM (%)
1.64 %
Debt to Equity
Debt to Equity
0.03
Institutions
Institutions
2.24 %
Individual < 2 lac
Individual < 2 lac
25.01 %
No. of Shareholders
No. of Shareholders
13,555
View more
Edit Ratio's

About

Albert David Limited (ADL) is a leading drug manufacturer based in Kolkata, India, specializin… Read more
Low
581
52W Range
High
959
  • Albert David
  • Shivalik Rasayan
  • Prevest Denpro
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Dosage Form Break-Up

Customer Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Customers

    • Government

    FAQs on Albert David Ltd. Business

    Albert David Limited, a leading Indian drug manufacturer based in Kolkata, offers a wide range of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and medical disposables. It is a key subsidiary of the Kothari Group, known for its advanced R&D and manufacturing capabilities.

    Albert David major competitors are Shivalik Rasayan, Prevest Denpro, Jenburkt Pharma, Medicamen Biotech, Kilitch Drugs(India), Medico Remedies, Trident Lifeline.
    Market Cap of Albert David is ₹457 Crs.
    While the median market cap of its peers are ₹411 Crs.

    Albert David seems to be less financially stable compared to its competitors.
    Altman Z score of Albert David is 2.9 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Albert David Ltd.
    How This Company Is Manipulating Its Cash From Operations - Dr Vijay Malik
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material